Literature DB >> 25209841

Relationship and factor structure in multisystem neurodegeneration in Parkinson's disease.

T Hattori1, S Orimo, M Hallett, T Wu, A Inaba, R Azuma, H Mizusawa.   

Abstract

OBJECTIVES: Parkinson's disease (PD) is a multisystem neurodegenerative disease. We aimed to identify the relationship and factor structure among its different features. MATERIALS &
METHODS: Motor, olfactory and cognitive function, and cardiac sympathetic denervation were evaluated in 125 patients with PD using the Unified Parkinson's Disease Rating Scale (UPDRS) part III score, odor stick identification test for the Japanese (OSIT-J), Mini-Mental State Examination (MMSE), and [(123) I] meta-iodobenzylguanidine (MIBG) cardiac scintigraphy (heart-to-mediastinum (H/M) ratio). Pearson's correlation and multiple regression analysis were used to evaluate the association among the four measures with age, gender, and disease duration as the covariates. Exploratory factor analysis was used to identify the underlying factor structure among the measures and covariates.
RESULTS: Pearson's correlation and multiple regression analysis showed correlations between OSIT-J score and MIBG H/M ratio, OSIT-J and MMSE scores, UPDRS part III score and MIBG H/M ratio, UPDRS part III score and disease duration, and MMSE score and age. Factor analysis identified three factors: (i) age and MMSE score; (ii) MIBG H/M ratio and OSIT-J score; and (iii) UPDRS part III score and disease duration.
CONCLUSIONS: Our results suggest that aging, PD-related pathogenesis, and disease duration underlie the multisystem neurodegeneration present in PD. Moreover, age and disease duration are the major risk factors for cognitive impairment and motor symptoms, respectively. Olfactory impairment and cardiac sympathetic denervation are strongly associated in PD.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Parkinson's disease; cardiac sympathetic degeneration; cognitive impairment; factor analysis; olfactory impairment; relationship

Mesh:

Year:  2014        PMID: 25209841      PMCID: PMC4208945          DOI: 10.1111/ane.12273

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  35 in total

1.  Olfactory dysfunction and cardiovascular dysautonomia in Parkinson's disease.

Authors:  Hisayoshi Oka; Chizuko Toyoda; Makiko Yogo; Soichiro Mochio
Journal:  J Neurol       Date:  2010-01-30       Impact factor: 4.849

2.  alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.

Authors:  Isabel Ubeda-Bañon; Daniel Saiz-Sanchez; Carlos de la Rosa-Prieto; Lucia Argandoña-Palacios; Susana Garcia-Muñozguren; Alino Martinez-Marcos
Journal:  Acta Neuropathol       Date:  2010-04-11       Impact factor: 17.088

Review 3.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

Authors:  Claire L Tomlinson; Rebecca Stowe; Smitaa Patel; Caroline Rick; Richard Gray; Carl E Clarke
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

4.  Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease.

Authors:  Mutsumi Iijima; Mikio Osawa; Mitsuru Momose; Tatsu Kobayakawa; Sachiko Saito; Makoto Iwata; Shinichiro Uchiyama
Journal:  Mov Disord       Date:  2010-07-15       Impact factor: 10.338

5.  Association of anosmia with autonomic failure in Parkinson disease.

Authors:  David S Goldstein; LaToya Sewell; Courtney Holmes
Journal:  Neurology       Date:  2010-01-19       Impact factor: 9.910

6.  Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Vikas Kotagal; Robert A Koeppe; Michael A Kilbourn; Roger L Albin; Kirk A Frey
Journal:  Brain       Date:  2010-04-22       Impact factor: 13.501

7.  Regional differences in the severity of Lewy body pathology across the olfactory cortex.

Authors:  Laura Silveira-Moriyama; Janice L Holton; Ann Kingsbury; Hilary Ayling; Aviva Petrie; William Sterlacci; Werner Poewe; Hans Maier; Andrew J Lees; Tamas Revesz
Journal:  Neurosci Lett       Date:  2009-02-10       Impact factor: 3.046

Review 8.  The morbid anatomy of dementia in Parkinson's disease.

Authors:  Michail E Kalaitzakis; Ronald K B Pearce
Journal:  Acta Neuropathol       Date:  2009-10-10       Impact factor: 17.088

9.  Cardiac sympathetic denervation is correlated with Parkinsonian midline motor symptoms.

Authors:  Joong-Seok Kim; Kwang-Soo Lee; In-Uk Song; Yeong-In Kim; Sung-Hoon Kim; I-Ryung You; Hee-Tae Kim
Journal:  J Neurol Sci       Date:  2008-04-18       Impact factor: 3.181

Review 10.  The relationship of Parkinson disease with aging.

Authors:  Gilberto Levy
Journal:  Arch Neurol       Date:  2007-09
View more
  2 in total

1.  Structural changes in Parkinson's disease: voxel-based morphometry and diffusion tensor imaging analyses based on 123I-MIBG uptake.

Authors:  Kazufumi Kikuchi; Akio Hiwatashi; Osamu Togao; Koji Yamashita; Ryo Somehara; Ryotaro Kamei; Shingo Baba; Hiroo Yamaguchi; Jun-Ichi Kira; Hiroshi Honda
Journal:  Eur Radiol       Date:  2017-07-04       Impact factor: 5.315

2.  A Card-type Odor Identification Test for Japanese Patients with Parkinson's Disease and Related Disorders.

Authors:  Yuji Watanabe; Keisuke Suzuki; Tomoyuki Miyamoto; Masayuki Miyamoto; Ayaka Numao; Hiroaki Fujita; Tomoyuki Uchiyama; Taro Kadowaki; Takeo Matsubara; Koichi Hirata
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.